Autoantibodies in neuromuscular transmission disorders
It is a great pleasure to be asked to honour the memory of Dr. Baldev Singh by reviewing the field of autoantibodies in myasthenia gravis and other neurotransmission disorders. The neuromuscular junction (NMJ) is the site of a number of different autoimmune and genetic disorders, and it is also the...
Main Author: | Vincent Angela |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2008-01-01
|
Series: | Annals of Indian Academy of Neurology |
Subjects: | |
Online Access: | http://www.annalsofian.org/article.asp?issn=0972-2327;year=2008;volume=11;issue=3;spage=140;epage=145;aulast=Vincent |
Similar Items
-
Autoantibody of NRIP, a novel AChR‐interacting protein, plays a detrimental role in myasthenia gravis
by: Li‐Kai Tsai, et al.
Published: (2021-06-01) -
Myasthenia Gravis With Antibodies Against Muscle Specific Kinase: An Update on Clinical Features, Pathophysiology and Treatment
by: Michelangelo Cao, et al.
Published: (2020-09-01) -
The Muscle Is Not a Passive Target in Myasthenia Gravis
by: Jean-Thomas Vilquin, et al.
Published: (2019-12-01) -
The Structure, Function, and Physiology of the Fetal and Adult Acetylcholine Receptor in Muscle
by: Hakan Cetin, et al.
Published: (2020-09-01) -
Myasthenia Gravis: From the Viewpoint of Pathogenicity Focusing on Acetylcholine Receptor Clustering, Trans-Synaptic Homeostasis and Synaptic Stability
by: Masaharu Takamori
Published: (2020-05-01)